AI Verdict
RNST has stronger fundamentals based on our AI analysis.
RNST vs RNAZ Fundamental Comparison
| Metric | RNST | RNAZ |
|---|---|---|
| Revenue | $1.3B | N/A |
| Net Income | $181.3M | $-21.2M |
| Net Margin | 14.4% | N/A |
| ROE | 4.7% | -1,488.0% |
| ROA | 0.7% | -406.0% |
| Current Ratio | N/A | 1.60x |
| Debt/Equity | 0.13x | 1.57x |
| EPS | $2.07 | $-34.49 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RNST vs RNAZ: Frequently Asked Questions
Is RNST or RNAZ a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RNST has stronger fundamentals. RNST is rated HOLD (70% confidence) while RNAZ is rated STRONG SELL (88% confidence). This is not investment advice.
How does RNST compare to RNAZ fundamentally?
RENASANT CORP has ROE of 4.7% vs Transcode Therapeutics, Inc.'s -1,488.0%. Net margins are 14.4% vs N/A respectively.
Which stock pays higher dividends, RNST or RNAZ?
RNST has a dividend yield of N/A or no dividend while RNAZ has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RNST or RNAZ for long term?
For long-term investing, consider that RNST has HOLD rating with 70% confidence, while RNAZ has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RNST vs RNAZ?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RNST vs RNAZ, the AI consensus favors RNST based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.